| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 08/25/1992 | US5141929 Lipophilic ethers and/or esters of d-desosamine and their compositions as anti-bacteria and anti-fungus agents |
| 08/25/1992 | US5141928 Ophthalmic medication |
| 08/25/1992 | US5141927 Antihypertensive preparation comprising an alginate and vitamin D |
| 08/25/1992 | US5141926 Erythromycin derivatives |
| 08/25/1992 | US5141925 Vivo methods for treating coccidiosis |
| 08/25/1992 | US5141736 Bispecific monoclonal antibody, its production and use |
| 08/25/1992 | US5141735 Viricides for AIDS treatment |
| 08/25/1992 | US5141575 Surface treatment for zinciferous surfaces |
| 08/25/1992 | CA1306755C Gabapentin monohydrate and a process for producing the same |
| 08/25/1992 | CA1306750C Process for the preparation of quinoline carboxylic acide |
| 08/25/1992 | CA1306749C .alpha.-ACYLAMINO AMINOALKYL PHOSPHONATE ANGIOTENSIN CONVERTING ENZYME INHIBITORS |
| 08/25/1992 | CA1306748C N-aminobutyl-n-phenylarylamide derivatives, their preparation and their application in therapy |
| 08/25/1992 | CA1306747C Process for the preparation of new heterocyclic derivatives which can be used especially as aldose reductase inhibitors |
| 08/25/1992 | CA1306746C Cyclic amino-thioacetal amides, a process for the preparation thereofand pharmaceutical compositions containing them |
| 08/25/1992 | CA1306744C Indole, benzofuran, benzothiophene containing lipoxygenase inhibiting compounds |
| 08/25/1992 | CA1306743C DOUBLE ESTER OF 16.beta.-ETHYLESTRAN-17.beta.-OL DERIVATIVES |
| 08/25/1992 | CA1306699C Fervescence composition containing 15-keto-pges |
| 08/25/1992 | CA1306698C Hemolysis depressant, and medical resin composition, medical implement and blood preserving liquid using the hemolysis depressant |
| 08/25/1992 | CA1306697C Anti-aids virus agent comprising a streptovaricin c derivative |
| 08/25/1992 | CA1306696C Anti-htlv-i agent comprising a streptovaricin c derivative |
| 08/25/1992 | CA1306695C Composition for treating retrovirus |
| 08/25/1992 | CA1306693C Pharmaceutical compositions having antineoplastic activity |
| 08/25/1992 | CA1306692C Penetration enhancers for transdermal delivery of systemic agents |
| 08/25/1992 | CA1306686C Pharmaceutical composition containing ibuprofen |
| 08/25/1992 | CA1306685C Pharmaceutical composition containing zinc complex of halo-substituted hydroxyquinoline |
| 08/25/1992 | CA1306684C Stabilisation of mercury-containing preservatives in ophthalmic medicaments |
| 08/25/1992 | CA1306681C Antioxidant metallo-organic treatment of inflammation |
| 08/25/1992 | CA1306677C Composition for transdermal therapeutic systems of loop diuretics and a process for its preparation |
| 08/23/1992 | WO1992014696A2 SUBSTITUTED α-AMINOALDEHYDES AND DERIVATIVES |
| 08/23/1992 | WO1992014452A1 Delayed release oral dosage forms for treatment of intestinal disorders |
| 08/23/1992 | CA2104602A1 Substituted .alpha.-aminoaldehydes and derivatives |
| 08/23/1992 | CA2061629A1 5-(substituted amino)-1,2,4- triazolo¬1,5-a|pyrimidine derivatives |
| 08/23/1992 | CA2061538A1 2-substituted quinolines, processes for their preparation and their use in medicaments |
| 08/23/1992 | CA2061363A1 Method of treating type i diabetes |
| 08/23/1992 | CA2061340A1 Method of treating type i diabetes |
| 08/22/1992 | WO1992014470A1 Treatment of esophageal cancer |
| 08/22/1992 | WO1991018868A1 Substituted guanidines having high binding to the sigma receptor and the use thereof |
| 08/22/1992 | CA2104449A1 Treatment of esophageal cancer |
| 08/22/1992 | CA2083269A1 Substituted guanidines having high binding to the sigma receptor and the use thereof |
| 08/22/1992 | CA2061557A1 New benzene derivatives having ngf production-promoting activity |
| 08/21/1992 | WO1992014732A1 Indoles useful as platelet activating factor antagonists |
| 08/21/1992 | WO1992014716A1 2,4-diaminoquinazolines derivatives for enhancing antitumor activity |
| 08/21/1992 | CA2101542A1 2,4-diaminoquinazolines derivatives for enhancing antitumor activity |
| 08/21/1992 | CA2100682A1 Indoles useful as platelet activating factor antagonists |
| 08/21/1992 | CA2061488A1 Combination of active substances comprising a sydnone imine and a hirudin |
| 08/21/1992 | CA2061456A1 4-pyrimidinone derivatives, their preparation and their application in therapy |
| 08/21/1992 | CA2060965A1 Piperidine derivatives |
| 08/20/1992 | WO1992014151A1 Purified lam and synthetic analogs thereof |
| 08/20/1992 | WO1992014150A1 Monoclonal antibodies against receptor-induced binding sites |
| 08/20/1992 | WO1992013950A2 NUCLEOTIDIC SEQUENCES CODING FOR VARIABLE REGIONS OF β CHAINS OF HUMAN T LYMPHOCYTE RECEPTORS, CORRESPONDING PEPTIDIC SEGMENTS AND DIAGNOSTIC AND THERAPEUTIC APPLICATIONS |
| 08/20/1992 | WO1992013873A1 Novel steroid esters |
| 08/20/1992 | WO1992013872A1 Novel steroids |
| 08/20/1992 | WO1992013864A1 Acylamino-alkyliden-hydroxy-bisphosphonic acids useful in the therapy of osteoarticular diseases |
| 08/20/1992 | WO1992013857A1 Process for producing ergolin derivatives |
| 08/20/1992 | WO1992013855A1 (2-imidazolin-2-ylamino) tetrahydroquinolaxines and methods for using same |
| 08/20/1992 | WO1992013851A1 Pharmaceutical product for the therapy of tumors, particularly ovarian and haemopoietic system tumors, containing quercetin compounds as active substances |
| 08/20/1992 | WO1992013850A1 Novel gamma-pyrones, gamma-pyridones and gamma-thiopyrones and their use as medicaments and method for producing them |
| 08/20/1992 | WO1992013844A1 Substituted 4,6-di-tertiary-butyl-5-hydroxy-pyrimidines |
| 08/20/1992 | WO1992013836A1 2-decarboxyl-2-hydroxyalkyl-5-trans prostaglandin f derivatives |
| 08/20/1992 | WO1992013561A1 Oxypurine nucleosides and their congeners, and acyl derivatives thereof, for improvement of hematopoiesis |
| 08/20/1992 | WO1992013552A1 Anti-aggregatory peptides containing an aromatic ester or amide |
| 08/20/1992 | WO1992013542A1 Application of biologically active polymers to obtain a medicament for the treatment of retrovirus infections |
| 08/20/1992 | WO1992013537A1 Iloprost effective against cerebral malaria |
| 08/20/1992 | WO1992013536A1 2-substituted-4,6-di-tertiary-butyl-5-hydroxy-1,3-pyrimidines useful as antiinflammatory agents |
| 08/20/1992 | WO1992013534A1 Pharmaceutical composition and use |
| 08/20/1992 | WO1992013533A1 Pharmaceutical compositions containing amethocaine |
| 08/20/1992 | WO1992013532A2 Naphthoquinone derivatives for the treatment of chronic inflammation |
| 08/20/1992 | WO1992013530A1 Transglutaminase enzyme inhibitors |
| 08/20/1992 | WO1992013527A1 Water-dispersible tablets |
| 08/20/1992 | WO1992013525A1 Synthetic membrane vesicles containing functionally active fusion peptides as drug delivery systems |
| 08/20/1992 | WO1992013522A1 Orthomolecular method of treating sickle cell disease |
| 08/20/1992 | WO1992013516A2 Improved antiperspirant formulations |
| 08/20/1992 | WO1992013515A1 Non-antibacterial tetracycline compositions possessing antiplaque properties |
| 08/20/1992 | WO1992013509A1 Treatment of atherosclerosis |
| 08/20/1992 | WO1992013452A1 Methods of use and compositions of r(-) fluoxetine |
| 08/20/1992 | WO1992012134A3 Certain aminomethyl phenylimidazole derivatives; a new class of dopamine receptor subtype specific ligands |
| 08/20/1992 | WO1992011017A3 Use of sialyllactose for the treatment of arthritis |
| 08/20/1992 | WO1992010473A3 2-decarboxyl-2-alkoxyalkyl prostaglandins as ocular hypotensives |
| 08/20/1992 | DE4104257A1 Verwendung von anellierten tetrahydropyridinessigsaeurederivaten fuer die behandlung neurologischer erkrankungen Use of fused tetrahydropyridinessigsaeurederivaten for the treatment of neurological disorders |
| 08/20/1992 | CA2365269A1 Substituted 4,6-di-tertiary-butyl-5-hydroxy-pyrimidines |
| 08/20/1992 | CA2103924A1 Novel steroids |
| 08/20/1992 | CA2103893A1 Monoclonal antibodies against receptor-induced binding sites |
| 08/20/1992 | CA2100453A1 Novel steroid esters |
| 08/20/1992 | CA2080119A1 Process for the production of ergoline derivatives |
| 08/20/1992 | CA2061447A1 Disubstituted ureas and thioureas derivatives |
| 08/19/1992 | EP0499586A1 Substituted benzofuranyl-piperidine as nootropic |
| 08/19/1992 | EP0499544A2 Use of tetrahydropiridin-derivatives as inhibitors of angiogenesis |
| 08/19/1992 | EP0499527A1 Beta-carboline derivatives, ligands of benzodiazepine receptors with inverse agonist and benzodiazepine antagonist effects and medicaments containing them |
| 08/19/1992 | EP0499521A1 Inhibitors of N-myristoyltransferase, their preparation process and pharmaceutical compositions containing them |
| 08/19/1992 | EP0499489A1 Polyhydroxycyclopentane derivatives, their preparation and their therapeutic use |
| 08/19/1992 | EP0499467A2 Use of quinones in the treatment of cancer or AIDS |
| 08/19/1992 | EP0499463A1 Use of branched chain amine acids for improving ventilation during sleep of neonates |
| 08/19/1992 | EP0499444A1 N-imidazolyl derivatives of substituted alkoxyimino tetrahydronaphthalenes and chromans |
| 08/19/1992 | EP0499416A2 Pyridine compounds as angiotensin II antagonists, processes for their preparation and pharmaceutical compositions containing them |
| 08/19/1992 | EP0499415A1 Pyridine and quinoline derivatives, processes for their manufacture and their use as angiotensin II antagonists |
| 08/19/1992 | EP0499414A2 Pyridine derivatives as angiotensin II antagonists, processes for their preparation and pharmaceutical compositions containing them |
| 08/19/1992 | EP0499399A1 Analgesic compositions |
| 08/19/1992 | EP0499348A1 Ovulation-inhibiting agent for hormonal contraception |
| 08/19/1992 | EP0499337A1 Use of tetra:hydro-thieno-pyrido-indole derivatives for the treatment of skin disorders |
| 08/19/1992 | EP0499327A1 Steroid compounds active on the cardiovascular system |